While CXCL8 and IL-6 were the most important factors that segregated Severe-Death solid tumors patients, CXCL8, CRP and IL-6 had important roles for segregation of patients with hematologic cancers (Figures 8A, B). The gene discussed is CXCL8; the disease is hematopoietic and lymphoid cell neoplasm.